DAWN

6.45

4.59% -0.31

Dopo l'orario di chiusura: 6.36 -0.09 -1.40%

Day One Biopharmaceuticals Inc (DAWN)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione

Precedente Chiudi:

$6.76

Aprire:

$6.76

Volume 24 ore:

1.34M

Relative Volume:

1.10

Capitalizzazione di mercato:

$803.74M

Reddito:

Utile/perdita netta:

$-167.48M

Rapporto P/E:

-3.3077

EPS:

-1.95

Flusso di cassa netto:

$-197.47M

1 W Prestazione:

-18.66%

1M Prestazione:

-11.28%

6M Prestazione:

-60.65%

1 anno Prestazione:

-60.62%

Intervallo 1D:

$6.35

$6.91

Intervallo di 1 settimana:

$6.26

$7.955

Portata 52W:

$6.26

$17.14

Day One Biopharmaceuticals Inc Stock (DAWN) Company Profile

Nome

Day One Biopharmaceuticals Inc

Settore

Healthcare (1153)

Industria

Biotechnology (676)

Telefono

650 484-0899

Indirizzo

2000 SIERRA POINT PARKWAY, SUITE 501, BRISBANE

Dipendente

181

Cinguettio

Prossima data di guadagno

Ultimi documenti SEC

DAWN's Discussions on Twitter

Confronta DAWN con altri titoli

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
DAWN Day One Biopharmaceuticals Inc	6.45	803.74M	0	-167.48M	-197.47M	-1.95
VRTX Vertex Pharmaceuticals Inc	424.99	128.84B	11.10B	-988.90M	-1.26B	-3.92
REGN Regeneron Pharmaceuticals Inc	527.78	65.38B	14.09B	4.50B	2.96B	39.28
ARGX Argen X Se Adr	549.65	39.67B	2.19B	833.04M	-1.28B	12.71
ALNY Alnylam Pharmaceuticals Inc	251.15	33.82B	2.35B	-269.70M	-75.39M	-2.09
ONC Beigene Ltd Adr	231.99	27.60B	3.81B	-644.79M	-669.77M	-6.24

Day One Biopharmaceuticals Inc Stock (DAWN) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2024-10-09	Reiterato	Needham	Buy
2024-08-01	Aggiornamento	BofA Securities	Underperform → Buy
2024-04-24	Reiterato	Needham	Buy
2023-04-25	Downgrade	BofA Securities	Buy → Underperform
2023-02-08	Iniziato	CapitalOne	Overweight
2023-02-03	Iniziato	Oppenheimer	Perform
2022-12-15	Iniziato	H.C. Wainwright	Buy
2022-12-14	Iniziato	Needham	Buy
2022-12-05	Iniziato	Goldman	Buy
2022-12-01	Iniziato	BofA Securities	Buy

Mostra tutto

Day One Biopharmaceuticals Inc Borsa (DAWN) Ultime notizie

08:13 AM

Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) Shares Purchased by Dimensional Fund Advisors LP - Defense World

08:13 AM

04:15 AM

Research Analysts Issue Forecasts for DAWN Q2 Earnings - Defense World

04:15 AM

02:37 AM

Needham & Company LLC Cuts Day One Biopharmaceuticals (NASDAQ:DAWN) Price Target to $27.00 - Defense World

02:37 AM

02:09 AM

Research Analysts Set Expectations for DAWN Q2 Earnings - Defense World

02:09 AM

May 09, 2025

Is Day One Biopharmaceuticals, Inc. (DAWN) the Low Risk High Reward Stock Set to Triple by 2030? - Insider Monkey

May 09, 2025

Analysts Issue Forecasts for DAWN Q1 Earnings - Defense World

May 09, 2025

10 Low Risk High Reward Stocks Set to Triple by 2030 - Insider Monkey

May 09, 2025

May 08, 2025

Day One Biopharmaceuticals (NASDAQ:DAWN) Shares Gap Up After Earnings Beat - Defense World

May 08, 2025

Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) Shares Sold by Mariner LLC - Defense World

May 08, 2025

Day one biopharmaceuticals highlights OJEMDA revenue growth and pipeline progress in Q1 2025 - MSN

May 08, 2025

Day One Biopharmaceuticals (NASDAQ:DAWN) Reaches New 12-Month Low Following Analyst Downgrade - Defense World

May 08, 2025

May 07, 2025

Day One Biopharma’s Earnings Call Highlights Growth - TipRanks

May 07, 2025

Day One Biopharmaceuticals (DAWN) Target Price Adjusted to $26 | DAWN Stock News - GuruFocus

May 07, 2025

Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) Q1 2025 Earnings Call Transcript - Insider Monkey

May 07, 2025

MetLife Investment Management LLC Raises Position in Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) - Defense World

May 07, 2025

Day One Biopharmaceuticals earnings beat by $0.07, revenue fell short of estimates - Investing.com Canada

May 07, 2025

Day One Biopharmaceuticals Reports Strong Q1 2025 Results - TipRanks

May 07, 2025